Frequent use of gabapentin for back pain may raise the risk of dementia by 29% and mild cognitive impairment by 85%, new study finds.

According to a large-scale observational study published in the journal Regional Anesthesia & Pain Medicine, patients who received frequent gabapentin prescriptions were significantly more likely to ...

New research shows strength of feeling among patients, carers and families when it comes impact of the illness - now leading ...

Neurodegenerative diseases are surging, yet our nation slumbers, unaware of the devastation ahead. This illusion of rarity perpetuates a deadly inaction that extends to all brain diseases. Alzheimer's ...

When plaque ruptures, it can cause clots that block blood flow and trigger heart attacks. The scan would help determine ...

Urgent care clinics are handing out fistfuls of antibiotics, steroids and opioids for conditions these drugs won't help, a ...

Coronary artery calcium scans can offer a more precise estimate of a patient’s chances for major cardiac events. Some ...

The national TOP UP clinical trial, a partnership between University of Sydney researchers and aged care providers, found ...

ZUNVEYL was approved in July 2024 by the U.S. Food and Drug Administration (FDA) for the treatment of mild-to-moderate dementia of the Alzheimer's type in adults. As a new generation of ...

Supported by InnoHK, an AI-assisted solution developed by CUHK's Microbiota I-Center, MOZAIC, has been successful in curing Clostridioides difficile infection. As of May, 48 patients have been treated ...

Is your brain aging faster than your chronological age? New research shows it could raise your risk of death and dementia ...

Have you ever met someone in their 60s who looks 42? Or, maybe that person is you. Some people maintain great health well into their later years of life. This can be a result of ...